Acorda Therapeutics: Rebuilding the Spinal Cord
Murray, F and Kolesnik, M and Enriquez, J and West, J (2004) Acorda Therapeutics: Rebuilding the Spinal Cord. Other. Harvard Business School.
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1225/604014
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic in-licensing choices, including what disease indication, what stage of development, how many molecules, and on what terms.
To allow students to examine a portfolio of choices and their impact on the overall business rather than on a single licensing decision.
New York, NY; United States; Biotechnology industry; start-up; 2003
|Item Type:||Report (Other)|
|Deposited By:||Miss Alexandra Lejda|
|Deposited On:||02 Jan 2008 17:03|
|Last Modified:||17 Jul 2008 02:41|
|ePrint Statistics:||View statistics for this ePrint|
Repository Staff Only: item control page